Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleophilic Substitution and Selective Oxidation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111548325A details a novel synthesis of 7-chloro-benzothiazepine-1,1-dioxide, offering improved yield and halogen introduction for reliable pharmaceutical intermediate supply chains.